Logo image of CMRE

COSTAMARE INC (CMRE) Stock Fundamental Analysis

NYSE:CMRE - New York Stock Exchange, Inc. - MHY1771G1026 - Common Stock - Currency: USD

10.47  -0.06 (-0.57%)

After market: 10.47 0 (0%)

Fundamental Rating

5

Overall CMRE gets a fundamental rating of 5 out of 10. We evaluated CMRE against 29 industry peers in the Marine Transportation industry. CMRE has an average financial health and profitability rating. CMRE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CMRE had positive earnings in the past year.
In the past year CMRE had a positive cash flow from operations.
Of the past 5 years CMRE 4 years were profitable.
CMRE had a positive operating cash flow in 4 of the past 5 years.
CMRE Yearly Net Income VS EBIT VS OCF VS FCFCMRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

The Return On Assets of CMRE (6.82%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 14.37%, CMRE is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
The Return On Invested Capital of CMRE (7.60%) is better than 60.71% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMRE is in line with the industry average of 8.54%.
Industry RankSector Rank
ROA 6.82%
ROE 14.37%
ROIC 7.6%
ROA(3y)7.68%
ROA(5y)6.3%
ROE(3y)16.9%
ROE(5y)14.5%
ROIC(3y)7.95%
ROIC(5y)7.33%
CMRE Yearly ROA, ROE, ROICCMRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

The Profit Margin of CMRE (17.61%) is comparable to the rest of the industry.
CMRE's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 21.51%, CMRE is in line with its industry, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Operating Margin of CMRE has declined.
CMRE has a worse Gross Margin (35.06%) than 67.86% of its industry peers.
CMRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.51%
PM (TTM) 17.61%
GM 35.06%
OM growth 3Y-23.56%
OM growth 5Y-11.69%
PM growth 3Y-35.05%
PM growth 5Y-0.3%
GM growth 3Y-21.64%
GM growth 5Y-13.44%
CMRE Yearly Profit, Operating, Gross MarginsCMRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMRE is creating some value.
CMRE has more shares outstanding than it did 1 year ago.
CMRE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CMRE has an improved debt to assets ratio.
CMRE Yearly Shares OutstandingCMRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CMRE Yearly Total Debt VS Total AssetsCMRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.38, we must say that CMRE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CMRE (1.38) is comparable to the rest of the industry.
CMRE has a debt to FCF ratio of 4.87. This is a neutral value as CMRE would need 4.87 years to pay back of all of its debts.
CMRE's Debt to FCF ratio of 4.87 is fine compared to the rest of the industry. CMRE outperforms 60.71% of its industry peers.
A Debt/Equity ratio of 0.75 indicates that CMRE is somewhat dependend on debt financing.
The Debt to Equity ratio of CMRE (0.75) is worse than 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 4.87
Altman-Z 1.38
ROIC/WACC0.98
WACC7.73%
CMRE Yearly LT Debt VS Equity VS FCFCMRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CMRE has a Current Ratio of 1.65. This is a normal value and indicates that CMRE is financially healthy and should not expect problems in meeting its short term obligations.
CMRE's Current ratio of 1.65 is in line compared to the rest of the industry. CMRE outperforms 46.43% of its industry peers.
CMRE has a Quick Ratio of 1.56. This is a normal value and indicates that CMRE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.56, CMRE is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.56
CMRE Yearly Current Assets VS Current LiabilitesCMRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CMRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.17%, which is quite impressive.
CMRE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.66% yearly.
Looking at the last year, CMRE shows a very strong growth in Revenue. The Revenue has grown by 37.88%.
Measured over the past years, CMRE shows a very strong growth in Revenue. The Revenue has been growing by 34.24% on average per year.
EPS 1Y (TTM)33.17%
EPS 3Y5.63%
EPS 5Y24.66%
EPS Q2Q%1.47%
Revenue 1Y (TTM)37.88%
Revenue growth 3Y37.96%
Revenue growth 5Y34.24%
Sales Q2Q%-10.44%

3.2 Future

Based on estimates for the next years, CMRE will show a decrease in Earnings Per Share. The EPS will decrease by -5.50% on average per year.
Based on estimates for the next years, CMRE will show a very negative growth in Revenue. The Revenue will decrease by -12.74% on average per year.
EPS Next Y-7.39%
EPS Next 2Y-5.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-16.92%
Revenue Next 2Y-12.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CMRE Yearly Revenue VS EstimatesCMRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CMRE Yearly EPS VS EstimatesCMRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 3.78, the valuation of CMRE can be described as very cheap.
Based on the Price/Earnings ratio, CMRE is valued a bit cheaper than 64.29% of the companies in the same industry.
CMRE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
The Price/Forward Earnings ratio is 4.08, which indicates a rather cheap valuation of CMRE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMRE indicates a somewhat cheap valuation: CMRE is cheaper than 78.57% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, CMRE is valued rather cheaply.
Industry RankSector Rank
PE 3.78
Fwd PE 4.08
CMRE Price Earnings VS Forward Price EarningsCMRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CMRE's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CMRE indicates a somewhat cheap valuation: CMRE is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.78
EV/EBITDA 4.2
CMRE Per share dataCMRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as CMRE's earnings are expected to decrease with -5.50% in the coming years.
PEG (NY)N/A
PEG (5Y)0.15
EPS Next 2Y-5.5%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.36%, CMRE is a good candidate for dividend investing.
The stock price of CMRE dropped by -26.73% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CMRE's Dividend Yield is comparable with the industry average which is at 14.52.
CMRE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 4.36%

5.2 History

The dividend of CMRE has a limited annual growth rate of 5.41%.
CMRE has paid a dividend for at least 10 years, which is a reliable track record.
CMRE has decreased its dividend recently.
Dividend Growth(5Y)5.41%
Div Incr Years0
Div Non Decr Years1
CMRE Yearly Dividends per shareCMRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CMRE pays out 20.19% of its income as dividend. This is a sustainable payout ratio.
DP20.19%
EPS Next 2Y-5.5%
EPS Next 3YN/A
CMRE Yearly Income VS Free CF VS DividendCMRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M
CMRE Dividend Payout.CMRE Dividend Payout, showing the Payout Ratio.CMRE Dividend Payout.PayoutRetained Earnings

COSTAMARE INC

NYSE:CMRE (2/21/2025, 8:10:15 PM)

After market: 10.47 0 (0%)

10.47

-0.06 (-0.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)02-05 2025-02-05/bmo
Earnings (Next)05-10 2025-05-10/bmo
Inst Owners26.99%
Inst Owner Change0.89%
Ins Owners64.11%
Ins Owner ChangeN/A
Market Cap1.25B
Analysts45.71
Price Target14.28 (36.39%)
Short Float %2.77%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield 4.36%
Yearly Dividend0.6
Dividend Growth(5Y)5.41%
DP20.19%
Div Incr Years0
Div Non Decr Years1
Ex-Date01-21 2025-01-21 (0.115)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.87%
Min EPS beat(2)4.17%
Max EPS beat(2)5.58%
EPS beat(4)3
Avg EPS beat(4)3.06%
Min EPS beat(4)-4.98%
Max EPS beat(4)7.47%
EPS beat(8)5
Avg EPS beat(8)-1.07%
EPS beat(12)8
Avg EPS beat(12)-0.52%
EPS beat(16)11
Avg EPS beat(16)0.24%
Revenue beat(2)2
Avg Revenue beat(2)39.2%
Min Revenue beat(2)30.49%
Max Revenue beat(2)47.91%
Revenue beat(4)4
Avg Revenue beat(4)32.67%
Min Revenue beat(4)20.32%
Max Revenue beat(4)47.91%
Revenue beat(8)7
Avg Revenue beat(8)26.02%
Revenue beat(12)9
Avg Revenue beat(12)17.09%
Revenue beat(16)9
Avg Revenue beat(16)12.34%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-12.75%
EPS NQ rev (3m)-12.75%
EPS NY rev (1m)-14.46%
EPS NY rev (3m)-14.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 3.78
Fwd PE 4.08
P/S 0.62
P/FCF 2.78
P/OCF 2.23
P/B 0.5
P/tB 0.5
EV/EBITDA 4.2
EPS(TTM)2.77
EY26.46%
EPS(NY)2.57
Fwd EY24.5%
FCF(TTM)3.77
FCFY35.98%
OCF(TTM)4.69
OCFY44.78%
SpS16.95
BVpS20.77
TBVpS20.77
PEG (NY)N/A
PEG (5Y)0.15
Profitability
Industry RankSector Rank
ROA 6.82%
ROE 14.37%
ROCE 9.62%
ROIC 7.6%
ROICexc 9.39%
ROICexgc 9.39%
OM 21.51%
PM (TTM) 17.61%
GM 35.06%
FCFM 22.23%
ROA(3y)7.68%
ROA(5y)6.3%
ROE(3y)16.9%
ROE(5y)14.5%
ROIC(3y)7.95%
ROIC(5y)7.33%
ROICexc(3y)9.69%
ROICexc(5y)8.54%
ROICexgc(3y)9.69%
ROICexgc(5y)8.54%
ROCE(3y)10.06%
ROCE(5y)9.27%
ROICexcg growth 3Y6.65%
ROICexcg growth 5Y10.82%
ROICexc growth 3Y6.65%
ROICexc growth 5Y10.82%
OM growth 3Y-23.56%
OM growth 5Y-11.69%
PM growth 3Y-35.05%
PM growth 5Y-0.3%
GM growth 3Y-21.64%
GM growth 5Y-13.44%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 4.87
Debt/EBITDA 3.09
Cap/Depr 67.19%
Cap/Sales 5.44%
Interest Coverage 2.93
Cash Conversion 93.45%
Profit Quality 126.23%
Current Ratio 1.65
Quick Ratio 1.56
Altman-Z 1.38
F-Score6
WACC7.73%
ROIC/WACC0.98
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.17%
EPS 3Y5.63%
EPS 5Y24.66%
EPS Q2Q%1.47%
EPS Next Y-7.39%
EPS Next 2Y-5.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)37.88%
Revenue growth 3Y37.96%
Revenue growth 5Y34.24%
Sales Q2Q%-10.44%
Revenue Next Year-16.92%
Revenue Next 2Y-12.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.84%
EBIT growth 3Y5.46%
EBIT growth 5Y18.54%
EBIT Next Year34.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y102.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.45%
OCF growth 3YN/A
OCF growth 5YN/A